← All compoundsBuy at AMP Peptides →Buy at Ascension Peptides →
peptide4 listings
ARA-290
ARA-290 (Cibinetide)
Erythropoietin-derived peptide. Neuropathy and tissue-repair research.
Neuropathy researchTissue repairAnti-inflammatory research
/ compare by size
Every source for ARA-290
Size:
2 sources for 10mg·cheapest $48.00 at AMP Peptides·$4.80/mg
Rank
Source
Trust Score
Price
$/mg
Buy
#1
AMP PeptidesBEST
★ 4.8
$48.00
$4.80/mg
#2
Ascension Peptides
★ 4.8
$79.99
$8.00/mg
/ research index
The research base
Research Maturity
★★★☆☆
3/5 — Volume of studies
Evidence Strength
★★★☆☆
3/5 — Quality of evidence
Innate repair receptor agonist studied for neuropathic pain and tissue protection without erythropoietic effects.
/ mechanism of action
How it works
Activates the innate repair receptor (IRR), modulating inflammation and promoting tissue repair without affecting red blood cell production.
/ research dosing
Common research protocols
Range
1-4 mg/day (trials used ~2-4mg subQ)
Frequency
Daily subcutaneous
Route
Subcutaneous
Cycle
4-12 week research courses
Research notes
Derived from the EPO molecule but lacks erythropoietic activity. Studied for small-fiber neuropathy and sarcoidosis-related pain.
References
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use
As a solo compound
Standalone use is standard for neuropathy research.
Common pairings
/ side effects
What to know
Generally well-tolerated in trials; injection-site effects possible.
/ timeline
Realistic expectations
4-8 weeks
/ recommendation
Where to buy ARA-290
🏆Our pick for ARA-290
AMP Peptides
10mg · USA · Card / Crypto
- ✓Third-party tested (Janoshik)
- ✓COAs provided — Per-batch
- ✓Highest verification tier in stock
- ✓4.8★ community rating
Also solid
FOR RESEARCH USE ONLY. ARA-290 is intended for laboratory research and not for human consumption.